Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Change at the top for Teleflex as Black resigns

This article was originally published in Clinica

Executive Summary

Jeffrey Black has resigned as the CEO of Teleflex after more than ten years in the position. The Menlo Park, California-based company said that Mr Black had resigned by mutual agreement but did not specify his reasons for departing. Benson Smith has become the firm’s new chairman, president and CEO of Teleflex, which is striving to become a pure-play medtech firm. Mr Smith has been a Teleflex board member since 2005; before joining the firm he spent 25 years at CR Bard, where he most recently held the role of president and chief operating officer. He is also chairman of cardiac resuscitation and AED firm Zoll Medical and a board member at urological catheter specialist Rochester Medical. Teleflex is focusing its operations on the medical device market – it recently purchased catheter navigation firm VasoNova for $55m (, 11 January 2011) and agreed to sell the actuation business of its Telair International subsidiary (, 2 December 2010).

You may also be interested in...

Alere aided by professional diagnostics sales in fourth quarter

Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.

Integra and Stout to work on expandable interbody device

Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.

Gen-Probe eyes portfolio expansion to help boost molecular diagnostics credentials

Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts